about
Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database.Comparisons of diabetic retinopathy events associated with glucose-lowering drugs in patients with type 2 diabetes mellitus: a network meta-analysis.Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database.SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis.Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. AdultsAssessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reportingAssessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting SystemTraditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance databaseSodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answersAssessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event ReportingReal-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's gangreneDipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled TrialsDipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults
P50
Q47727860-AEC731FC-13D9-421E-8EB2-8317042A1281Q48167241-F4E6AC14-C32F-4FC5-AD95-6FBF24A69942Q49722271-708C2F5C-6060-4A60-B32E-D2071C4D6259Q51244548-0E0176AC-A97F-4091-938E-B3F429C6016BQ59624366-4893710C-4F17-4180-A633-77E0C1AA18AEQ89768695-141ABFEB-4A3F-4F3B-96A9-99445C3BD99AQ90364000-396F1816-A3C0-479D-B62E-7C9A5B10CDA0Q90549739-D13C5947-CCB4-4D3A-AC1B-A221C700D4ECQ91274913-B1E05675-1C92-4F23-B7E9-BE803923B53CQ92171047-862F9ECF-1A92-4130-A774-8FCE16EC757FQ92771783-859588B9-6FB8-4532-A429-B79057560467Q92916242-D4B9ECE5-A2E1-4608-BB7C-1F4ABE273CF9Q93021754-3402D9A5-AB71-4920-9BA8-AE5536575A7B
P50
description
researcher
@en
name
Tiansheng Wang
@en
type
label
Tiansheng Wang
@en
prefLabel
Tiansheng Wang
@en
P31
P496
0000-0002-0980-8896